Dr. James L. McCarley, Jr., Chairman and CEO of Cantrell Drug Company, https://cantrelldrug.com/, a 503B Registered Outsourcing Facility, announced that his Company has received final approval from the FDA to begin producing and shipping product under the terms and conditions of a Consent Decree Agreement with the FDA that was signed on April 19th of this year.
September 25, 2018
· 1 min read